Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
doi: 10.3389/fnut.2022.962312 Received 06 June 2022 Accepted 13 September 2022 Published 06 February 2023 Volume 9 - 2022 Edited by Xianli Gao, Jiangsu University, China Reviewed by Danjun Guo, Wuhan Polytechnic University, China
Children or their care givers were asked to rate the intensity of each individual symptom on a validated 5-point Likert scale (0 indicates no problem, 1 indicates mild problem, 2 indicates moderate problem, 3 indicates severe problem and 4 indicates very severe problem)
Timing: Any time of day
Pharmacological profile of lixisenatide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes
US$ 24.95
US$ 21.44
US$ 20.55
US$ 24.40
US$ 22.58
US$ 25.88
US$ 21.35
